Evidence map›Paper›PMID 40302696›Full record

ArticleActa oncologica (Stockholm, Sweden)2025

Mental illness and non-metastatic colorectal cancer treatment and survival, a nationwide study of almost 70,000 patients.

Erik Osterman, Elisavet Syriopoulou, Anna Martling, Therese M-L Andersson, Caroline Nordenvall

Abstract read
In one paragraph

Article in Acta oncologica (Stockholm, Sweden), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erik OstermanDepartment of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; Department of Surgical Sciences, Uppsala University and Department of Surgery, Uppsala University Hospital, Uppsala, Sweden. erik.osterman@ki.se.ORCID 0000-0003-1621-7872
Elisavet SyriopoulouDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-5749-4094
Anna MartlingDepartment of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; Department of Pelvic Cancer, Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0001-5998-4735
Therese M-L AnderssonDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0001-8644-9041
Caroline NordenvallDepartment of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; Department of Pelvic Cancer, Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-5112-8894

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe impact of mental illness on treatment and outcomes for patients with colorectal cancer (CRC) has not been investigated with potential confounders and mediators accounted for. PATIENTS AND

methodsColorectal Cancer Database (CRCBaSe), a linked national registry database, was used to analyse stage I-III CRC patients diagnosed in Sweden between 2008 and 2021. The exposure of interest was a history of mental illness. Treatment outcomes were analysed with logistic regressions. Flexible parametric models were fitted for survival analysis. Analyses were adjusted for pre-specified confounders.

resultsPatients with a history of severe mental illness presented with more advanced tumours and comorbidities. They were more likely to undergo emergency surgery (OR 1.56, 95% CI 1.32-1.84) and less likely to receive adjuvant treatment (OR 0.65, 95% CI 0.53-0.80) than patients with no history of mental illness. Five-year standardised overall survival (OS) was worse for those with a history of mild and severe mental illness, 64.6% (95%CI 63.9-65.3) and 61.8% (95%CI 59.7-63.8) compared to those without 69.3% (95%CI 68.9-69.7). Although time to recurrence was not significantly impacted, standardised survival after recurrence was worse for patients with a history of severe mental illness, with a 3-year survival after recurrence of 24% compared to 30% in those without a history of mental illness.

interpretationAlthough the differences were smaller compared to previous studies, patients with a history of mental illnesses still do worse. The management of CRC patients with psychiatric comorbidities presents complex challenges necessitating personalised solutions.

Indexed as

Colorectal NeoplasmsMental DisordersAdultAgedAged, 80 and overComorbidityFemaleHumansMaleMiddle AgedNeoplasm StagingRegistriesSurvival RateSweden

Identifiers

PMID40302696
PMCPMC12053378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.